logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
V

Vamsidhar Velcheti

New York University

19H-index
69Paper Count
2.1KCitation Count
Published Papers 13
Publication Date
logo
Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment
errnpj Precision Oncology
IF8
err2025-10-28
err0
errOAAI
errKevin Lu; John Paul Shen; Fernando J. Lopez-Diaz; Alessandro Leal; Isa Mambetsariev; Kaushal Parikh; Antonious Hazim; Brian D. Woodward; Abhinav Madduri; Faisal Khurshid; Jeremy Fricke; Vamsidhar Velcheti; Jonathan W. Riess; Aaron S. Mansfield; Ravi Salgia; Hatim Husain
errShare
errSave
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis
errJTO CLINICAL AND RESEARCH REPORTS
IF3.5
err2025-01-01
err0
errOAAI
errStalker, Margaret; Grady, Connor B.; Watts, Alex; Hwang, Wei-Ting; Chandrasekhara, Krishna; Sun, Fangdi; Liu, Geoffrey; Patel, Devalben; Nieva, Jorge; Herrmann, Amanda; Marrone, Kristen; Lam, Vincent K.; Velcheti, Vamsidhar; Liu, Stephen, V; Montenegro, Gabriela Liliana Bravo; Tompkins, William; Patil, Tejas; Weiss, Jared; Miller, Kelsey Leigh; Schwartzman, William; Dowell, Jonathan E.; Shaverdashvili, Khvaramze; Villaruz, Liza; Cass, Amanda; Iams, Wade; Aisner, Dara; Aggarwal, Charu; Camidge, D. Ross; Sun, Lova; Marmarelis, Melina E.
errShare
errSave
Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan
errFRONTIERS IN ONCOLOGY
IF3.3
err2024-04-30
err0
errOAAI
errAbu Hejleh, Taher; Alsawalha, Karim; Abdel Hafiz, Sufian; Al-Batsh, Tamer; Abu Hejleh, Roaa; Yaser, Sameer; Abu Jazar, Husam; Khader, Jamal; Alnsour, Anoud; Mohamad, Issa; Abdel Jalil, Riad; Abu-Shanab, Ahmad; Gharaibeh, Azza; Abu Shattal, Mohammad; Alibraheem, Akram; Haddad, Hussam; Mahmoud, Naser; Obeidat, Shadi; Al-Jaghbeer, Mohammed J.; Furqan, Muhammad; Cortellini, Alessio; Velcheti, Vamsidhar; Al-rabi, Kamal
errShare
errSave
Preliminary pharmacodynamic characterization in patients with platinum-resistant ovarian cancer treated with nemvaleukin in combination with pembrolizumab
errCANCER RESEARCH
IF16.6
err2024-03-04
err0
PREAI
errWiner, Ira; Vaishampayan, Ulka N.; Gilbert, Lucy; Gandhi, Shipra; Velcheti, Vamsidhar; Dalal, Rita; Du, Yangchun; Donatelli, Sarah; Panchabhai, Sonali; Strauss, James F.; Piha-Paul, Sarina
errShare
errSave
Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices
errFRONTIERS IN ONCOLOGY
IF3.3
err2022-10-17
err14
errOAAI
errLiu, Stephen V.; Hu, Xiaohan; Li, Yeran; Zhao, Bin; Burke, Thomas; Velcheti, Vamsidhar
errShare
errSave
Immunotherapy in non-small cell lung cancer: Past, present, and future directions
errFRONTIERS IN ONCOLOGY
IF3.3
err2022-08-02
err50
errOAAI
errPunekar, Salman R. R.; Shum, Elaine; Grello, Cassandra Mia; Lau, Sally C. C.; Velcheti, Vamsidhar
errShare
errSave
Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1
errFRONTIERS IN ONCOLOGY
IF3.3
err2022-03-25
err24
errOAAI
errVelcheti, Vamsidhar; Hu, Xiaohan; Yang, Lingfeng; Pietanza, M. Catherine; Burke, Thomas
errShare
errSave
Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices
errSCIENTIFIC REPORTS
IF3.9
err2021-04-28
err49
errOAAI
errVelcheti, Vamsidhar; Hu, Xiaohan; Piperdi, Bilal; Burke, Thomas
errShare
errSave
Pembrolizumab for Previously Treated, PD-L1-expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival
errCLINICAL LUNG CANCER
IF3.3
err2020-09-01
err9
errOAAI
errVelcheti, Vamsidhar; Chandwani, Sheenu; Chen, Xin; Piperdi, Bilal; Burke, Thomas
errShare
errSave
Real-world outcomes of first-line pembrolizumab monotherapy for PD-L1-positive (TPS ≥50%) metastatic non-small cell lung cancer (NSCLC)
errCANCER RESEARCH
IF16.6
err2019-07-01
err0
PREAI
errVelcheti, Vamsidhar; Chandwani, Sheenu; Chen, Xin; Pietanza, M. Catherine; Burke, Thomas
errShare
errSave
Rational design of anti-GITR-based combination immunotherapy
errNATURE MEDICINE
IF50
err2019-04-29
err182
errOAAI
errZappasodi, Roberta; Sirard, Cynthia; Li, Yanyun; Budhu, Sadna; Abu-Akeel, Mohsen; Liu, Cailian; Yang, Xia; Zhong, Hong; Newman, Walter; Qi, Jingjing; Wong, Phillip; Schaer, David; Koon, Henry; Velcheti, Vamsidhar; Hellmann, Matthew D.; Postow, Michael A.; Callahan, Margaret K.; Wolchok, Jedd D.; Merghoub, Taha
errShare
errSave
Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2017-10-17
err41
errOAAI
errCarvajal-Hausdorf, Daniel E.; Mani, Nikita; Velcheti, Vamsidhar; Schalper, Kurt A.; Rimm, David L.
errShare
errSave
Objective Measurement and Clinical Significance of TILs in Non-Small Cell Lung Cancer
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2015-02-03
err267
errOAAI
errSchalper, Kurt A.; Brown, Jason; Carvajal-Hausdorf, Daniel; McLaughlin, Joseph; Velcheti, Vamsidhar; Syrigos, Konstantinos N.; Herbst, Roy S.; Rimm, David L.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
J
Jedd D. Wolchok
H-index: 173 · Papers: 1.4K
R
Roy S. Herbst
H-index: 134 · Papers: 1.3K
D
David L. Rimm
H-index: 134 · Papers: 1.5K
M
Matthew D. Hellmann
H-index: 116 · Papers: 836
D
D. Ross Camidge
H-index: 110 · Papers: 999
View more